Cipla Ltd
Tofacitinib (11mg)
Tofajak-IN XR 11mg Tablet is used to treat moderate to severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis.
Tablet ER
Tofajak-IN XR 11mg Tablet may be prescribed by itself or in combination with another medicine. The tablets can be taken with or without food and it is best to take them at the same time each day. Your dose will depend on your condition and what other medicines you are taking. You should use it as your doctor tells you to. Do not stop taking this medicine unless your doctor tells you to because your condition could get worse.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Tofajak-IN XR 11mg Tablet may be taken with or without food, but it is better to take it at a fixed time.
Tofajak-IN XR 11mg Tablet is a Janus kinase inhibitor. It works by blocking the action of the enzyme Janus kinase. This decreases the activity of the immune system and inflammation associated with rheumatic diseases and ulcerative colitis.
Tofajak-IN XR 11mg Tablet can make it a bit harder for people to fight off infections. Inform your doctor if you have symptoms of an infection such as fever, chills, cough, and muscle aches. Your doctor may get TB (tuberculosis) skin test and a chest X-ray before starting treatment with this medication. Inform your doctor if you are pregnant, planning to conceive, or breastfeeding.
Tell your doctor about any pre-existing liver conditions before starting Tofajak-IN XR 11mg Tablet. This is because in some cases, Tofajak-IN XR 11mg Tablet may increase liver enzymes. Therefore, your liver function should be evaluated before starting this medication. While Tofajak-IN XR 11mg Tablet can be prescribed to patients with mild to moderate liver dysfunction, it should not be given to those with severe liver impairment.
Tofajak-IN XR 11mg Tablet may increase the risk of developing certain cancers (lymphoma and other cancers, including skin cancers) by affecting the immune system. Inform your doctor if you ever had or have any type of cancer.
Tofajak-IN XR 11mg Tablet is approved for use in people with moderate to severe rheumatoid arthritis. It's an inflammatory disease of the joints that affects joint mobility and function. This medication can be used if previous treatments were ineffective or not suitable for the individual, but it may also be used earlier in treatment if someone doesn't respond well to prescribed medications.
Tofajak-IN XR 11mg Tablet usually takes about 2 to 8 weeks before you start feeling better, and it can take 3 to 6 months to reach maximum effect.
You may need blood tests before or during treatment with Tofajak-IN XR 11mg Tablet. Blood tests check for low red blood cell count (anemia), low white blood cell count (neutropenia or lymphopenia), high blood fat (cholesterol) or elevated liver enzymes. These tests help ensure that Tofajak-IN XR 11mg Tablet is not causing any side effects and to check if you have a risk of certain infections. Your doctor may also advise tuberculosis testing before starting Tofajak-IN XR 11mg Tablet as using this medication may worsen an existing infection.
Tofajak-IN XR 11mg Tablet affects your immune system, which may decrease your ability to fight infection and increase the risk of getting a serious infection. These include tuberculosis, and fungal, bacterial or viral infections that spread throughout the body. In some cases, these infections can be life-threatening and cause death. Therefore, seeking medical attention in a hospital setting is recommended for treatment.
No, you should not take tocilizumab along with Tofajak-IN XR 11mg Tablet. Tofajak-IN XR 11mg Tablet affects the immune system, so avoid combining it with other medications that affect immunity. Doing so can further increase the risk of infection and lead to further complications.